home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630299.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
36 lines
Document 0299
DOCN M9630299
TI Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for
the treatment of AIDS.
DT 9603
AU Rice WG; Supko JG; Malspeis L; Buckheit RW Jr; Clanton D; Bu M; Graham
L; Schaeffer CA; Turpin JA; Domagala J; et al; Laboratory of Antiviral
Drug Mechanisms, PRI/DynCorp., National; Cancer Institute-Frederick
Cancer Research and Development; Center, MD 21702, USA.
SO Science. 1995 Nov 17;270(5239):1194-7. Unique Identifier : AIDSLINE
MED/96072970
AB Strategies for the treatment of human immunodeficiency virus-type 1
(HIV-1) infection must contend with the obstacle of drug resistance.
HIV-1 nucleocapsid protein zinc fingers are prime antiviral targets
because they are mutationally intolerant and are required both for acute
infection and virion assembly. Nontoxic disulfide-substituted benzamides
were identified that attack the zinc fingers, inactivate cell-free
virions, inhibit acute and chronic infections, and exhibit broad
antiretroviral activity. The compounds were highly synergistic with
other antiviral agents, and resistant mutants have not been detected.
Zinc finger-reactive compounds may offer an anti-HIV strategy that
restricts drug-resistance development.
DE Amino Acid Sequence Animal Antiviral
Agents/CHEMISTRY/*PHARMACOLOGY/PHARMACOKINETICS
Benzamides/CHEMISTRY/*PHARMACOLOGY/PHARMACOKINETICS Biological
Availability Capsid/*ANTAGONISTS & INHIB/CHEMISTRY Cell Line
Disulfides/CHEMISTRY/*PHARMACOLOGY/PHARMACOKINETICS Drug Resistance,
Microbial Drug Synergism Gene Products, gag/*ANTAGONISTS &
INHIB/CHEMISTRY Human HIV-1/*DRUG EFFECTS/PHYSIOLOGY Male Mice
Molecular Sequence Data Support, U.S. Gov't, P.H.S. Zinc Fingers/*DRUG
EFFECTS JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).